Search results
Unraveling the link between the microbiome and esophageal cancer
Medical Xpress· 4 days agoEsophageal cancer (EC) has two primary subtypes: esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC). Despite ...
Is that mole melanoma? How to tell if a mole is cancerous or not
TODAY via Yahoo News· 6 days agoMcMichael says doctors will look at the tumor’s depth, how quickly cells are dividing and other...
Rakuten Medical Announces Poster Presentation and Booth Exhibition at ASCO 2024 Annual Meeting
WDTN-TV 2 Dayton· 3 days agoSAN DIEGO, May 9, 2024 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy based ...
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 7 days agoInvestors' focus will likely be on Iovance's (IOVA) progress with its ongoing commercial launch for...
How Is Seborrheic Dermatitis Treated?
Health via Yahoo News· 1 day agoYou can apply these treatments to the scalp 1-2 times weekly. Potential side effects of long-term use may include folliculitis, contact dermatitis (an...
Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira...
WPRI Providence· 22 hours agoCevira (APL-1702) is a photodynamic drug-device combination product in development for the non-surgical treatment of high-grade squamous intraepithelial ...
Immunosuppression Risk Factor for Poor cSCC Outcomes
Medscape· 3 days agoIn contrast to earlier findings, immunosuppression was an independent risk factor for disease-specific death and major poor outcomes.
Adlai Nortye Ltd. (NASDAQ:ANL) Short Interest Update
ETF DAILY NEWS· 1 day agoAdlai Nortye Ltd. (NASDAQ:ANL – Get Free Report) saw a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 11,500 shares, a growth of 101.8% ...
How mRNA vaccines could be personalized cancer cures
Axios· 6 days agoWhy it matters: This personalized approach could make conditions like melanoma and bladder, kidney, pancreatic and breast cancers treatable, and even...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 14 hours agoPomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (NASDAQ: CKPT) and certain officers. The class action ...